Vermillion Supports First World Ovarian Cancer Day
Thursday, May 16, 2013
Vermillion offers women new hope with OVA1, a FDA-cleared test designed to aid in the prediction of malignancy prior to surgery on an ovarian mass.
Vermillion Reports First Quarter 2013 Results
Thursday, May 16, 2013
Building upon early success of OVA1, recent funding sets stage for 2013-2015 strategic plan.
SYGNIS Licenses Amplification Buffer to QIAGEN
Thursday, May 16, 2013
This is the second agreement with QIAGEN within 9 months.
TriLink BioTechnologies Announces Worldwide License with QuantiBact A/S
Thursday, May 16, 2013
TriLink BioTechnologies, Inc. announced that it has signed a licensing agreement with QuantiBact A/S to offer twisted intercalating nucleic acid (TINA) modified oligos.
A Cautionary Tale on Genome-Sequencing Diagnostics for Rare Diseases
Tuesday, May 14, 2013
Studies in several children have raising new questions about inheritance, genomic sequencing, and diagnostic.
Mass Spectrometry-Based Proteomics in Molecular Diagnostics: Discovery of Cancer Biomarkers Using Tissue Culture
Monday, May 13, 2013
Rapid development of MS-based proteomic techniques in the last decade that has immensely helped researchers in candidate biomarker discovery.
Phenomenex to Host AACC Workshop on LC/MS/MS for Clinical Diagnostics
Friday, May 10, 2013
Two-day, hands-on program to be held May 15 and 16.
Agilent Technologies Announces Winner of Fifth Annual Early Career Professor Award
Friday, May 10, 2013
Assistant Professor at Northwestern Recognized for Cancer Diagnostics Research.
OGT Supports Earlier Lupus Diagnosis
Friday, May 10, 2013
Superior sensitivity and specificity compared to current laboratory tests.
|
|
|
| << | 1 2 3 4 5 6 7 | >> | | Showing Results 11 - 20 of 1021 |
|
|
